ArticleThe Journal of clinical investigation2019

Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice.

Yufeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.